Do transcriptomic biomarkers from a single endomyocardial biopsy improve the accurate diagnosis of myocarditis?
Transcriptomic biomarkers from endomyocardial biopsies may improve the diagnostic accuracy for myocarditis and other inflammatory heart diseases.
Together, these findings demonstrate that transcriptomic biomarkers from a single endomyocardial biopsy can improve the clinical detection of patients with inflammatory diseases of the heart. This approach advances the clinical management and treatment of cardiac disorders with highly variable outcome.
Heidecker et al. (Tue,) studied this question.